Combined LAI Treatment: Cabenuva and Sublocade for opioid-related disorders

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trials ended early. Its trials were stopped early. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 1 Apr 2022: Trial started, NCT05991622
  2. 14 Aug 2023: Trial registered, NCT05991622
  3. 18 Feb 2026: Trial withdrawn, NCT05991622

The trials

NCT05991622: Combined Injectable Treatment for HIV and OUD

State
Withdrawn before it started
Phase
Phase 2
People
0 taking part
Started
1 Apr 2022
Primary completion
27 Aug 2025
Arms
Preliminary Test of Combined LAI Treatment
Results
None posted
  1. 1 Apr 2022: Trial started
  2. 14 Aug 2023: Trial registered
  3. 18 Feb 2026: Trial withdrawn

How the status changed

  1. 19 Nov 2026: First set: Trials ended early

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.